| Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin “resistance” F Santilli, B Rocca, R De Cristofaro, S Lattanzio, L Pietrangelo, A Habib, ... Journal of the American College of Cardiology 53 (8), 667-677, 2009 | 308 | 2009 |
| The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes B Rocca, F Santilli, D Pitocco, L Mucci, G Petrucci, E Vitacolonna, ... Journal of Thrombosis and Haemostasis 10 (7), 1220-1230, 2012 | 280 | 2012 |
| Platelet activation in obesity and metabolic syndrome F Santilli, N Vazzana, R Liani, MT Guagnano, G Davi Obesity reviews 13 (1), 27-42, 2012 | 274 | 2012 |
| Effects of PEEP on the intracranial system of patients with head injury and subarachnoid hemorrhage: the role of respiratory system compliance A Caricato, G Conti, F Della Corte, A Mancino, F Santilli, C Sandroni, ... Journal of Trauma and Acute Care Surgery 58 (3), 571-576, 2005 | 245 | 2005 |
| Soluble forms of RAGE in human diseases: clinical and therapeutical implications F Santilli, N Vazzana, LG Bucciarelli, G Davi Current medicinal chemistry 16 (8), 940-952, 2009 | 224 | 2009 |
| Soluble forms of RAGE in internal medicine N Vazzana, F Santilli, C Cuccurullo, G Davì Internal and emergency medicine 4, 389-401, 2009 | 208 | 2009 |
| Role of growth factors in the development of diabetic complications F Chiarelli, F Santilli, A Mohn Hormone Research in Paediatrics 53 (2), 53-67, 2000 | 207 | 2000 |
| Nutraceuticals in diabetes and metabolic syndrome G Davì, F Santilli, C Patrono Cardiovascular therapeutics 28 (4), 216-226, 2010 | 206 | 2010 |
| Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration G Davì, F Chiarelli, F Santilli, M Pomilio, S Vigneri, A Falco, S Basili, ... Circulation 107 (25), 3199-3203, 2003 | 204 | 2003 |
| Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss MR Manigrasso, P Ferroni, F Santilli, T Taraborelli, MT Guagnano, ... The Journal of Clinical Endocrinology & Metabolism 90 (10), 5876-5879, 2005 | 196 | 2005 |
| Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss MR Manigrasso, P Ferroni, F Santilli, T Taraborelli, MT Guagnano, ... The Journal of Clinical Endocrinology & Metabolism 90 (10), 5876-5879, 2005 | 196 | 2005 |
| Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian … A Di Castelnuovo, M Bonaccio, S Costanzo, A Gialluisi, A Antinori, ... Nutrition, Metabolism and Cardiovascular Diseases 30 (11), 1899-1913, 2020 | 191 | 2020 |
| Soluble RAGE in type 2 diabetes: association with oxidative stress E Devangelio, F Santilli, G Formoso, P Ferroni, L Bucciarelli, N Michetti, ... Free Radical Biology and Medicine 43 (4), 511-518, 2007 | 190 | 2007 |
| Oxidative stress in chronic vascular disease: from prediction to prevention F Santilli, D D'Ardes, G Davi Vascular pharmacology 74, 23-37, 2015 | 164 | 2015 |
| Insulin resistance as a determinant of platelet activation in obese women S Basili, G Pacini, MT Guagnano, MR Manigrasso, F Santilli, C Pettinella, ... Journal of the American College of Cardiology 48 (12), 2531-2538, 2006 | 163 | 2006 |
| Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins F Santilli, L Bucciarelli, D Noto, AB Cefalù, V Davì, E Ferrante, C Pettinella, ... Free Radical Biology and Medicine 43 (9), 1255-1262, 2007 | 153 | 2007 |
| Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control F Cipollone, F Chiarelli, G Davi, C Ferri, G Desideri, M Fazia, A Iezzi, ... Diabetologia 48, 1216-1224, 2005 | 151 | 2005 |
| CD40/CD40L system and vascular disease F Santilli, S Basili, P Ferroni, G Davi Internal and emergency medicine 2, 256-268, 2007 | 142 | 2007 |
| Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus F Santilli, G Davì, A Consoli, F Cipollone, A Mezzetti, A Falco, ... Journal of the American College of Cardiology 47 (2), 391-397, 2006 | 140 | 2006 |
| Platelets and diabetes mellitus F Santilli, P Simeone, R Liani, G Davì Prostaglandins & other lipid mediators 120, 28-39, 2015 | 137 | 2015 |
